Schedule 13G ownership disclosure

AVENUE THERAPEUTICS INC

Security class unavailable · CUSIP: 05360L205

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
661,056
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-24-000011
Form type
SC 13G/A
Filer
AVENUE THERAPEUTICS, INC.
CIK
CIK 1644963
Filed
Jan 02, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub